Type 2 diabetes, the most common form of diabetes in humans, is characterized by impaired insulin secretion paralleled by a progressive decline in beta-cell function and chronic insulin resistance. Several authors have showed that in type 2 diabetes there is a reduction of islet and/or insulin-containing cell mass or volume. Regulation of the beta-cell mass appears to involve a balance of beta-cell replication and apoptosis but, at the molecular level, pancreatic beta-cell loss by apoptosis appears to play an important role in the development of insulin deficiency and the onset and/or progression of the disease. The mechanisms favoring apoptosis in type 2 diabetic pancreatic islets and new potential therapeutic approaches to prevent beta-cell death and maintain beta-cell mass are discussed.
|Autori:||LUPI R; DEL PRATO S|
|Titolo:||ß-cell apoptosis in type 2 diabetes: quantitative and functional consequences|
|Anno del prodotto:||2008|
|Digital Object Identifier (DOI):||10.1016/S1262-3636(08)73396-2|
|Appare nelle tipologie:||1.1 Articolo in rivista|